
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Mantle cell lymphoma—Update on molecular biology, prognostication and treatment approaches
Elisabeth Silkenstedt, Martin Dreyling
Hematological Oncology (2023) Vol. 41, Iss. S1, pp. 36-42
Open Access | Times Cited: 24
Elisabeth Silkenstedt, Martin Dreyling
Hematological Oncology (2023) Vol. 41, Iss. S1, pp. 36-42
Open Access | Times Cited: 24
Showing 24 citing articles:
The Role of Transglutaminase 2 in Cancer: An Update
Elisabetta Zaltron, Federica Vianello, Alessia Ruzza, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2797-2797
Open Access | Times Cited: 10
Elisabetta Zaltron, Federica Vianello, Alessia Ruzza, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2797-2797
Open Access | Times Cited: 10
Updates on the Biological Heterogeneity of Mantle Cell Lymphoma
Andrew Ip, Maciej Kabat, Lindsay Fogel, et al.
Cancers (2025) Vol. 17, Iss. 4, pp. 696-696
Open Access
Andrew Ip, Maciej Kabat, Lindsay Fogel, et al.
Cancers (2025) Vol. 17, Iss. 4, pp. 696-696
Open Access
The optimal time and clinical implications of measurable residual disease detection in mantle cell lymphoma
Yuting Yan, Yanshan Huang, Ying Yu, et al.
Annals of Hematology (2025)
Open Access
Yuting Yan, Yanshan Huang, Ying Yu, et al.
Annals of Hematology (2025)
Open Access
Mantle Cell Lymphoma: what clinical progress in the last 5 years?
Charbel Soueidy, Jean‐Marie Michot, Vincent Ribrag
Expert Opinion on Investigational Drugs (2025), pp. 1-17
Closed Access
Charbel Soueidy, Jean‐Marie Michot, Vincent Ribrag
Expert Opinion on Investigational Drugs (2025), pp. 1-17
Closed Access
Composite mantle cell lymphoma with cryptic ins(11;2)(q13;p11.2p11.2)/IGK::CCND1 and lymphoplasmacytic lymphoma with MYD88 L265P mutation
Fumiyo Maekawa, Masahiko Hayashida, Kayo Takeoka, et al.
Cancer Genetics (2025) Vol. 294-295, pp. 15-20
Closed Access
Fumiyo Maekawa, Masahiko Hayashida, Kayo Takeoka, et al.
Cancer Genetics (2025) Vol. 294-295, pp. 15-20
Closed Access
Empowering macrophages: the cancer fighters within the tumour microenvironment in mantle cell lymphoma
Patrick Nylund, Anna Nikkarinen, Sara Ek, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Patrick Nylund, Anna Nikkarinen, Sara Ek, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Biological and Clinical Determinants Shaping Heterogeneity in Mantle Cell Lymphoma
Cristina López, Elisabeth Silkenstedt, Martin Dreyling, et al.
Blood Advances (2024) Vol. 8, Iss. 14, pp. 3652-3664
Open Access | Times Cited: 3
Cristina López, Elisabeth Silkenstedt, Martin Dreyling, et al.
Blood Advances (2024) Vol. 8, Iss. 14, pp. 3652-3664
Open Access | Times Cited: 3
Survival Outcomes of Patients with Mantle Cell Lymphoma: A Retrospective, 15-Year, Real-Life Study
Emanuele Cencini, Natale Calomino, Marta Franceschini, et al.
Hematology Reports (2024) Vol. 16, Iss. 1, pp. 50-62
Open Access | Times Cited: 1
Emanuele Cencini, Natale Calomino, Marta Franceschini, et al.
Hematology Reports (2024) Vol. 16, Iss. 1, pp. 50-62
Open Access | Times Cited: 1
Insight into Mantle Cell Lymphoma Pathobiology, Diagnosis, and Treatment Using Network-Based and Drug-Repurposing Approaches
Georgia Orfanoudaki, Konstantina Psatha, Michalis Aivaliotis
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7298-7298
Open Access | Times Cited: 1
Georgia Orfanoudaki, Konstantina Psatha, Michalis Aivaliotis
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7298-7298
Open Access | Times Cited: 1
Longevity Effects of Target of Rapamycin and Phosphatidylinositol 3-Kinase Inhibitors and Other Autophagy-Related Supplements in y w Male Drosophila melanogaster
Aaron A. Bearden, Emily M. Stewart, Candace C. Casher, et al.
(2024)
Open Access | Times Cited: 1
Aaron A. Bearden, Emily M. Stewart, Candace C. Casher, et al.
(2024)
Open Access | Times Cited: 1
Conditional survival of younger patients with mantle cell lymphoma: Results from a randomized phase III trial of the European MCL Network
Linmiao Jiang, Martin Dreyling, Olivier Hermine, et al.
British Journal of Haematology (2024) Vol. 206, Iss. 1, pp. 159-166
Open Access | Times Cited: 1
Linmiao Jiang, Martin Dreyling, Olivier Hermine, et al.
British Journal of Haematology (2024) Vol. 206, Iss. 1, pp. 159-166
Open Access | Times Cited: 1
The Role of mTOR in B Cell Lymphoid Malignancies: Biologic and Therapeutic Aspects
Eleni A. Karatrasoglou, Maria Dimou, Alexia Piperidou, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 14110-14110
Open Access | Times Cited: 4
Eleni A. Karatrasoglou, Maria Dimou, Alexia Piperidou, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 14110-14110
Open Access | Times Cited: 4
Clinical Approach to Advanced Mantle Cell Lymphoma: A Detailed Case Analysis
Hamza Oualhadj, Ayoub Rafei, Fatima ezzahra Bouanani, et al.
International Journal of Innovative Science and Research Technology (IJISRT) (2024), pp. 3307-3311
Open Access
Hamza Oualhadj, Ayoub Rafei, Fatima ezzahra Bouanani, et al.
International Journal of Innovative Science and Research Technology (IJISRT) (2024), pp. 3307-3311
Open Access
Effects of Target of Rapamycin and Phosphatidylinositol 3-Kinase Inhibitors and Other Autophagy-Related Supplements on Life Span in y w Male Drosophila melanogaster
Aaron A. Bearden, Emily M. Stewart, Candace C. Casher, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 21, pp. 11504-11504
Open Access
Aaron A. Bearden, Emily M. Stewart, Candace C. Casher, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 21, pp. 11504-11504
Open Access
Rituximab, gemcitabine and oxaliplatin in relapsed or refractory indolent and mantle cell lymphoma: results of a multicenter phase I/II-study of the German Low Grade Lymphoma Study Group
Gabriel Scheubeck, Martin Hoffmann, Vindi Jurinović, et al.
Annals of Hematology (2024) Vol. 103, Iss. 7, pp. 2373-2380
Open Access
Gabriel Scheubeck, Martin Hoffmann, Vindi Jurinović, et al.
Annals of Hematology (2024) Vol. 103, Iss. 7, pp. 2373-2380
Open Access
Mantle Cell Lymphoma Under the Scope of Personalized Medicine: Perspective and Directions
Lara Gallucci Figorelle, Peterson Tiago Galvão, Felipe Matheus Ribeiro de Lima, et al.
Clinical Lymphoma Myeloma & Leukemia (2024) Vol. 24, Iss. 7, pp. 433-445
Closed Access
Lara Gallucci Figorelle, Peterson Tiago Galvão, Felipe Matheus Ribeiro de Lima, et al.
Clinical Lymphoma Myeloma & Leukemia (2024) Vol. 24, Iss. 7, pp. 433-445
Closed Access
Development of disseminated intravascular coagulation in asymptomatic leukemic non-nodal mantle cell lymphoma
Takumi Kondo, K Ohara, Shohei Yoshida, et al.
Annals of Hematology (2024)
Closed Access
Takumi Kondo, K Ohara, Shohei Yoshida, et al.
Annals of Hematology (2024)
Closed Access
Outcomes after treating advanced mantle cell lymphoma in a low‐income group at a Latin American center: The role of outpatient hematopoietic stem cell transplantation
José Carlos Jaime‐Pérez, Marcela Hernández‐Coronado, Mariana González‐Treviño, et al.
Hematological Oncology (2024) Vol. 42, Iss. 3
Closed Access
José Carlos Jaime‐Pérez, Marcela Hernández‐Coronado, Mariana González‐Treviño, et al.
Hematological Oncology (2024) Vol. 42, Iss. 3
Closed Access
Blastoid Variant Mantle Cell Lymphoma with Amplified <i>IGH/CCND1</i> Fusion: A Unique Case and Current Literature Review
Emine Göktaş, Sumeyye Sanal, Hacı Hasan Esen, et al.
Medical Bulletin of Haseki (2024) Vol. 62, Iss. 2, pp. 124-127
Open Access
Emine Göktaş, Sumeyye Sanal, Hacı Hasan Esen, et al.
Medical Bulletin of Haseki (2024) Vol. 62, Iss. 2, pp. 124-127
Open Access
EBV‐Positive Pleomorphic Variant Transformation of CD5‐Negative Mantle Cell Lymphoma: A Rare Case Report and Literature Review
Amy Song, Julie Li, Samuel G Cockey, et al.
Case Reports in Hematology (2024) Vol. 2024, Iss. 1
Open Access
Amy Song, Julie Li, Samuel G Cockey, et al.
Case Reports in Hematology (2024) Vol. 2024, Iss. 1
Open Access
Focal adhesion kinase as a new player in the biology of onco-hematological diseases: the starting evidence
Guido Capasso, Nayla Mouawad, Maria Castronuovo, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
Guido Capasso, Nayla Mouawad, Maria Castronuovo, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
Translocations can drive expression changes of multiple genes in regulons covering entire chromosome arms
Anna Oncins, Roser Zaurín, Houyem Toukabri, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Anna Oncins, Roser Zaurín, Houyem Toukabri, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Diagnosis and management of mantle cell lymphoma: a consensus practice statement from the Australasian Lymphoma Alliance
Allison Barraclough, Catherine Tang, Masa Lasica, et al.
Internal Medicine Journal (2024)
Closed Access
Allison Barraclough, Catherine Tang, Masa Lasica, et al.
Internal Medicine Journal (2024)
Closed Access
The optimal time and clinical implications of measurable residual disease detection in mantle cell lymphoma
Shuhua Yi, Yuting Yan, Yanshan Huang, et al.
Research Square (Research Square) (2023)
Open Access
Shuhua Yi, Yuting Yan, Yanshan Huang, et al.
Research Square (Research Square) (2023)
Open Access